Fidelity Investments’s Select Medical SEM Stock Holding History

Fidelity Investments’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$492K	Buy	29,775 +5,071	+21%	+$83.6K	﹤0.01%	3290
2026 Q1	$402K	Sell	24,704 -45,787	-65%	-$716K	﹤0.01%	3207
2025 Q4	$1.05M	Buy	70,491 +7,387	+12%	+$104K	﹤0.01%	2834
2025 Q3	$810K	Buy	63,104 +111	+0.2%	+$1.48K	﹤0.01%	2866
2025 Q2	$956K	Buy	62,993 +37	+0.1%	+$577	﹤0.01%	2736
2025 Q1	$1.05M	Sell	62,956 -10,923	-15%	-$201K	﹤0.01%	2660
2024 Q4	$1.39M	Sell	73,879 -48,082	-39%	-$927K	﹤0.01%	2561
2024 Q3	$2.29M	Sell	121,961 -563,848	-82%	-$10.8M	﹤0.01%	2358
2024 Q2	$13M	Buy	685,809 +140,984	+26%	+$2.4M	﹤0.01%	1792
2024 Q1	$8.85M	Buy	544,825 +174,648	+47%	+$2.56M	﹤0.01%	1915
2023 Q4	$4.69M	Sell	370,177 -140,561	-28%	-$1.77M	﹤0.01%	2088
2023 Q3	$6.95M	Sell	510,738 -111,440	-18%	-$1.72M	﹤0.01%	1939
2023 Q2	$10.7M	Buy	622,178 +139,314	+29%	+$2.16M	﹤0.01%	1840
2023 Q1	$6.73M	Sell	482,864 -91,538	-16%	-$1.35M	﹤0.01%	2010
2022 Q4	$7.68M	Buy	574,402 +118,162	+26%	+$1.53M	﹤0.01%	1995
2022 Q3	$5.43M	Sell	456,240 -83,271	-15%	-$1.18M	﹤0.01%	2142
2022 Q2	$6.87M	Sell	539,511 -156,376	-22%	-$2.01M	﹤0.01%	2127
2022 Q1	$8.99M	Buy	695,887 +695,301	+118,652%	+$9.18M	﹤0.01%	2161
2021 Q4	$10K	Sell	586 -39	-6%	-$666	﹤0.01%	3647
2021 Q3	$13K	Sell	625 -333	-35%	-$6.61K	﹤0.01%	3552
2021 Q2	$22K	Buy	958 +500	+109%	+$10.4K	﹤0.01%	3360
2021 Q1	$8K	Sell	458 -4	-0.9%	-$66	﹤0.01%	3452
2020 Q4	$7K	Hold	462	–	–	﹤0.01%	3387
2020 Q3	$5K	Hold	462	–	–	﹤0.01%	3323
2020 Q2	$3K	Sell	462 -455	-50%	-$3.77K	﹤0.01%	3342
2020 Q1	$7K	Sell	917 -523	-36%	-$6.21K	﹤0.01%	3194
2019 Q4	$19K	Hold	1,440	–	–	﹤0.01%	3127
2019 Q3	$13K	Sell	1,440 -973	-40%	-$8.51K	﹤0.01%	3178
2019 Q2	$20K	Buy	2,413 +371	+18%	+$2.93K	﹤0.01%	3074
2019 Q1	$15K	Sell	2,042 -87	-4%	-$699	﹤0.01%	3039
2018 Q4	$17K	Sell	2,129 -820	-28%	-$7.84K	﹤0.01%	2926
2018 Q3	$29K	Buy	+2,949	New	+$30.5K	﹤0.01%	2928
2014 Q4	–	Sell	-639,455	Closed	-$4.14M	–	2831
2014 Q3	$4.14M	Sell	639,455 -270,913	-30%	-$2.09M	﹤0.01%	2274
2014 Q2	$7.65M	Sell	910,368 -31,626	-3%	-$245K	﹤0.01%	2138
2014 Q1	$6.32M	Buy	941,994 +164,070	+21%	+$995K	﹤0.01%	2154
2013 Q4	$4.87M	Buy	+777,924	New	+$3.8M	﹤0.01%	2177

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Fidelity Investments's SEM Position: Q2 2026 in Review

Fidelity Investments increased its Select Medical (SEM) stake by 21% in Q2 2026, buying an estimated $83.6K and bringing the position to 29,775 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #3290.

Fidelity Investments first reported a position in SEM in Q4 2013 and has held it in 36 quarters since. The position peaked at $13M in Q2 2024. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Fidelity Investments held 29,775 shares of Select Medical worth $492K as of Q2 2026.
Fidelity Investments bought 5,071 Select Medical shares in Q2 2026, an estimated $83.6K.
Select Medical made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3290 holding.
Fidelity Investments first reported a position in Select Medical in Q4 2013 and has held it in 36 quarters since.
Fidelity Investments's Select Medical position peaked at $13M in Q2 2024.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.